Inflammasome Therapeutics
Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees
Inflammasome Therapeutics is a science‑based pharmaceutical company focused on developing therapies for degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular degeneration, and Parkinson’s disease. Based in Newton, Massachusetts, the firm operates with a small team and concentrates on advancing treatments that address inflammation-related pathways implicated in these conditions. The company positions itself within the pharmaceutical manufacturing and biotech space by pursuing long‑acting approaches to inflammasome‑mediated diseases, seeking to broaden options for patients with these prevalent disorders. A notable recent development is the first patient dosed in a geographic atrophy clinical trial, reflecting ongoing progress in its investigational program. The organization’s activities are framed around identifying and developing compounds to treat inflammasome‑driven disease, with collaborations and partnerships historically cited in industry coverage as part of its progression.
1-888-653-2347 
support@leadiq.com 
